Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 4/20 | 0.42 |
| ▸ | PDE4A | P27815 | 3/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.42 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.42 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 3/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GPR18 | Q14330 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 2/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16046188 | 0.95 | CYP3A4 (0.46) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL19913007 | 0.88 | CYP3A4 (0.61) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL16046791 | 0.87 | TSHR (0.41) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL11001667 | 0.85 | CYP3A4 (0.55) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL23004642 | 0.85 | PDE4A (0.40) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL16046844 | 0.83 | CYP3A4 (0.43) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL17539235 | 0.81 | CYP3A4 (0.44) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL16046697 | 0.80 | ADORA2B (0.45) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL22899035 | 0.80 | PDE4A (0.56) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL16047961 | 0.80 | ADORA2B (0.45) | ADORA2BPDE4AADORA2APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140272606-A1 | LITHIUM-ION SECONDARY BATTERY AND ELECTROLYTE THEREOF | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2014-09-18 | — | — | US | claimed |
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
| US-20140272606-A1 | LITHIUM-ION SECONDARY BATTERY AND ELECTROLYTE THEREOF | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210020991-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY | SLC9B2, SLC9A1, SLC9A2 | ADORA2B 2628/4885PDE4A 3232/4885ADORA2A 4139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.